PD
Pizzuti Dana
Chief Med and Dev Officer
OFFICERF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Pizzuti Dana, Chief Med and Dev Officer. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Cumulatively, 22 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €237k. History available since 10 October 2022. The latest transaction was filed on 1 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pizzuti Dana
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
5,000 股@ US$16.890.0016% mcap25.1% 占其流量Common StockSEC:0001628280-25-055054:0
5,000 股@ US$16.892.8% 占其流量Common StockSEC:0001628280-25-049671:0
5,000 股@ US$16.890.0016% mcap24.9% 占其流量Common StockSEC:0001658247-25-000013:0
5,000 股@ US$16.892.8% 占其流量Common StockSEC:0001948238-25-000009:0
30,000 股@ US$16.8917.6% 占其流量Common StockSEC:0001948238-25-000007:0
6,492 股@ US$29.187.9% 占其流量Common StockSEC:0001948238-25-000005:0
2,388 股@ US$34.173.7% 占其流量Common StockSEC:0000950170-25-043407:0
43,000 股0Common StockSEC:0000950170-25-025665:0
5,000 股@ US$16.894.1% 占其流量Common StockSEC:0000950170-25-014557:0
15,000 股@ US$16.8912.1% 占其流量Common StockSEC:0000950170-25-002869:0
14,375 股@ US$16.8910.8% 占其流量Common StockSEC:0000950170-24-113082:0
14,375 股@ US$16.8911.1% 占其流量Common StockSEC:0000950170-24-081878:0
9,500 股@ US$16.897.4% 占其流量Common StockSEC:0000950170-24-077402:0
14,375 股@ US$16.8911.2% 占其流量Common StockSEC:0000950170-24-045142:0
4,375 股@ US$16.893.3% 占其流量Common StockSEC:0001209191-24-005061:0
411 股@ US$38.140.7% 占其流量Common StockSEC:0001209191-24-005013:0
23,000 股0Common StockSEC:0001209191-24-004607:0
14,375 股@ US$16.8910.9% 占其流量Common StockSEC:0001209191-24-000816:0
9,583 股@ US$16.897.3% 占其流量Common StockSEC:0001209191-23-059628:0
4,288 股@ US$15.983.1% 占其流量Common StockSEC:0001209191-23-023469:0
4,500 股0Common StockSEC:0001209191-23-015609:0
12,500 股0Common StockSEC:0001209191-22-053313:0
About Pizzuti Dana
Dana Pizzuti is Chief Med and Dev Officer at Crinetics Pharmaceuticals, Inc. She has 22 filings in total. Among the sampled recent filings, they cover the period from 2022-10-11 to 2025-12-03, with EUR 0 in buys and EUR 237172 in sells, and the most frequent transaction nature is Option exercise.